Published in Retina

The Ultimate Guide to Identifying Retinal Disease on Fundus Photography

This is editorially independent content
22 min read

This guide covers fundus findings for common retinal pathologies and a downloadable cheat sheet with widefield fundus imaging.

The Ultimate Guide to Identifying Retinal Disease on Fundus Photography
Fundus photography involves capturing detailed images of the retina using a specialized fundus camera, and plays a crucial role in diagnosing and managing a wide range of ocular and posterior segment diseases.
In 1886, Jackman and Webster first published photographs of the retina, marking the beginning of advances in retinal imaging, which were further revolutionized by the introduction of the first commercial fundus camera by Carl Zeiss in 1926.1
Significant innovations followed, including:1
  • Metzger’s stereoscopic photographs in 1927
  • Attachment of an electronic flash tube by Hansell and Beeson in 1953
  • Invention of the digital camera by Steven Sasson in 1975
  • Development of modern technologies like confocal scanning laser ophthalmoscopy and widefield, non-mydriatic cameras from companies such as ZEISS, Canon, and Topcon
Fundus photography is a powerful diagnostic tool that plays an instrumental role in the detection, monitoring, and management of retinal diseases. Advances in technology in fundus photography have made it indispensable for both routine and complex eyecare.
Optometrists need a solid understanding of image interpretation to identify early signs of retinal pathology and to provide optimal patient care. This guide will cover key retinal pathologies identified on a funduscopic exam, interpretation of relevant biomarkers, and the latest developments in fundus imaging technology.

Fundus photography for retinal disease detection and monitoring

Fundus photography captures detailed images of the retina, allowing clinicians to evaluate the optic nerve head, macula, retinal blood vessels, and the surrounding areas for abnormalities.
These images serve to document the current state of the retina, establishing baseline data for future reference, and can assist with monitoring for progression and assessment of treatment effectiveness.
Fundus photography offers several key advantages in the management of retinal and ocular diseases. Early detection is one of its primary benefits, as subtle retinal changes can often be identified before symptoms manifest, allowing for prompt intervention.
Serial imaging further enhances its utility by enabling the monitoring of disease progression over time, which is particularly critical in chronic conditions such as diabetic retinopathy (DR) and age-related macular degeneration (AMD).
Additionally, fundus photographs provide permanent, high-resolution visual documentation that can be shared with other specialists for collaborative care, as well as with patients for education about their condition and treatment options.

Modalities and special features of fundus photography

Widefield fundus imaging

Widefield fundus imaging offers a much broader view of the retina than traditional fundus photography. By capturing up to 200 to 300° of the retinal surface, this technique is invaluable for assessing the peripheral retina, a region often involved in conditions such as retinal detachment, DR, and retinal vascular occlusions.2
Widefield and ultra-widefield imaging are particularly useful additions to the dilated fundus exam for careful inspection of ischemia and neovascularization in peripheral regions that might be missed with standard imaging.3 These are fast, noninvasive methods that are increasingly used for the management of conditions with retinal pathology.
📚

Widefield Fundus Exams for Retinal Pathology Cheat Sheet

This cheat sheet outlines key retinal pathology and relevant biomarkers that can be imaged with widefield fundus photography.

Fundus autofluorescence (FAF)

Fundus autofluorescence (FAF) is a noninvasive imaging technique that provides detailed information about the retina's health, especially in the macula and peripheral regions.
It works by capturing the natural fluorescence emitted by retinal structures, primarily lipofuscin, when exposed to specific wavelengths of light. This allows for the visualization of retinal abnormalities, such as areas of atrophy, degeneration, or lipid accumulation, which may not be apparent on traditional imaging.4
FAF imaging is particularly valuable in monitoring retinal conditions that affect the retinal pigment epithelium (RPE), such as AMD, DR, and inherited retinal dystrophies. It can detect early changes in the RPE before visible structural changes are seen on other imaging modalities, such as optical coherence tomography (OCT) or fundus photography.
Widefield FAF, similar to widefield fundus photography, extends the visualization to the peripheral retina, helping to identify pathological changes outside the central macula.
This broad coverage is crucial for comprehensive assessment, as many retinal pathologies, including diabetic macular edema, retinal vein occlusions, and inherited retinal disorders, can have peripheral manifestations.
Furthermore, FAF is helpful in monitoring disease progression and response to treatment, providing clinicians with essential information for managing retinal conditions effectively.
Like widefield imaging, FAF is a rapid, noninvasive technique that enhances the ability to detect subtle changes across the entire retina, aiding in early diagnosis and timely intervention. As such, it is increasingly incorporated into routine clinical practice for the management of a variety of retinal diseases.

An overview of fundus findings

Table 1: Key landmarks found in a normal fundus exam of a healthy retina.
StructureTypical FindingsCommon Pathologies
Optic DiscRound or slightly oval, neuroretinal rim respecting the ISNT rule, symmetric cup-to-disc ratio in both eyesGlaucoma: Optic disc cupping, asymmetry in cup-to-disc ratio, breaking ISNT rule
Macula (Macula lutea + fovea centralis)Small, dark, circular area in the central retina, free of lesions, hemorrhages, or abnormalities; central depression reflects light, flat and free of pigment, blood, or lesions, foveal reflex present in younger patientsMacular degeneration: Drusen, geographic atrophy, macular edema; Macular edema: Thickening, cystoid spaces
Retinal vasculatureArteries lighter than veins, A/V ratio 2:3, vessels uniformly small with no arteriolar narrowing or vascular nickingDiabetic retinopathy: Microaneurysms, hemorrhages, cotton wool spots, neovascularization; Hypertensive retinopathy: Widening of arteriolar light reflex, copper-wiring of arterioles, hemorrhaging, cotton wool spots, hard exudates, retinal edema
Retinal background / posterior poleSmooth, even coloration; absence of hemorrhages, exudates, or pigmentary changes in the macular region and peripheryDiabetic retinopathy: Hard exudates, hemorrhages; Hypertensive retinopathy: Flame-shaped hemorrhages, cotton wool spots, arterial narrowing
Retinal peripheryTapered vessels with less density, vitreous base meets ora serrata, visible dentate processes at retinal peripheryRetinal detachment: Retinal tears, peripheral ischemia, subretinal fluid
Figure 1: Labeled fundus photograph of key landmarks outlined in Table 1.
Healthy retina landmarks
Figure 1: Courtesy of Inrava Khasnabish, OD, FAAO.

Clinical application of fundus photography

The management of a variety of retinal pathologies is enhanced with retinal photography, as it is used for documentation of a condition in its current state, detecting subtle changes over time, and in some cases, confirmation of a diagnosis.
Common key conditions in which fundus photography is a critical aspect of clinical management are outlined below, along with characteristic clinical biomarkers and clinical pearls that assist in both diagnosis and management.

Diabetic retinopathy (DR)

Diabetic retinopathy is the most common cause of vision loss in working-age adults in the US, and is characterized by vascular damage leading to ischemia, swelling, and eventually vasoproliferation in the retina.5 Early stages often do not exhibit symptoms, while pathologic changes are visible on fundus photography.6,7
As DR progresses from non-proliferative to proliferative, and as diabetic macular edema (DME) may ensue, fundus photography can be instrumental in noticing subtle changes as well as confirming the stage and making proper referral decisions.
In addition, DR is a particularly poignant example of when to use fundus photos to assist in patient education. Visualizing retinal bleeding can often have a meaningful impact on patients who have not yet fully recognized their risk of vision loss with continued medication or diet noncompliance, for example.
Table 2: Breakdown of DR stages with corresponding descriptions of clinical characteristics on fundus imaging.8,9
DR StageFundus AppearanceDescription
Mild non-proliferative diabetic retinopathy (NPDR)Retinal microaneurysmsTiny, round, red spots appearing on the retina, often seen in the peripheral retina
Retinal hemorrhagesDot or blot-shaped hemorrhages, typically in the outer plexiform and inner nuclear layers, visible as small red dots
ExudatesYellowish, well-defined deposits in the retina, often around the macula, indicating lipid and protein accumulation
Moderate NPDRCotton wool spotsWhite, fluffy patches in the retina, usually near the optic disc or in the posterior pole, signifying nerve fiber layer infarctions
Venous beadingBead-like dilations and tortuosity of retinal veins, seen as irregular, dilated veins in the mid-peripheral retina
Severe NPDRIntraretinal microvascular abnormalities (IRMAs)Abnormal, dilated, tortuous vessels in the retina, often visible as abnormal, branching blood vessels in the mid-peripheral retina, indicating ischemia
Proliferative diabetic retinopathy (PDR)Vitreous hemorrhagePresence of blood in the vitreous cavity, visible as hazy or clouded areas obscuring the retinal view
Retinal neovascularizationNew, abnormal blood vessels, often seen at the optic disc or on the retinal surface, appear as fine, fragile, irregular vessels that may be in the process of growing or bleeding
Diabetic macular edema (DME)DMESwelling of the macula, often accompanied by lipid exudates, is visible as thickening in the macular region, which may cause loss of the normal foveal reflex

Fundus photography pearls for DR:

  • Using an image swap or overlay feature in photography software can assist in identifying subtle changes. Early detection is crucial for preventing progression to severe stages.
  • Using a red-free filter on most fundus cameras (emitting green light at 570nm) assists in viewing blood vessels and aids in evaluating their caliber, crossing changes, or the presence of pathology.10
  • Patients with mobility issues, for whom sitting through dilated fundus exams can be challenging, may benefit from photography-guided dilated fundus exams.
    • This type of exam relies on both a fundus photo in addition to a dilated fundus exam to closely evaluate retinal health and screen for diabetic changes.
  • Widefield photography offers increased visibility for evaluating retinal changes pertaining to diabetic retinopathy outside of the posterior pole, which may not be as easily visualized during a dilated fundus exam alone
  • Widefield swept-source OCT angiography provides a non-invasive, high-resolution alternative to fluorescein angiography and ultra-widefield fundus photography for detecting diabetic retinopathy lesions, bleeding, and edema.11
  • Photography allows for time-consuming comparison and analysis that fundus examination often does not.
    • Simple zoom features, as well as enhancement filters or tools, can be used to inspect high-risk areas for early neovascularization. For example, cotton-wool spots will often predict the future location of IRMA and retinal neovascularization.
  • Photography can be used in addition to OCT in the close monitoring of mild center-involving (CI)-DME when acuity is 20/30 or better, as seen in Figure 2 below.
Figure 2: Fundus photograph of moderate NPDR with center-involving macular edema.
Mild NPDR
Figure 2: Courtesy of Inrava Khasnabish, OD, FAAO.

Age-related macular degeneration (AMD)

A leading cause of central vision loss in the elderly, AMD occurs as either dry (nonexudative) or wet (exudative or neovascular). Dry AMD is most common, occurring in 90% of affected individuals, while 10% progress to wet AMD.8,9
Table 3: Breakdown of AMD stages with corresponding descriptions of clinical characteristics on fundus imaging.8,9
AMD StageFundus AppearanceDescription
Dry AMD (nonexudative)DrusenSmall, yellowish deposits under the retina, often clustered near the macula; drusen are a hallmark of early dry AMD
Geographic atrophyWell-defined areas of retinal thinning and atrophy, particularly in the macular region, leading to visible tissue loss
Wet AMD (exudative / neovascular)Pigment epithelial detachments (PEDs)Elevated areas of the retina, often with a “tear-drop” shape, caused by fluid accumulation beneath the RPE
Subretinal hemorrhagesRed or dark patches on the retina, often around the macula, indicating bleeding from abnormal blood vessels
Choroidal neovascular membrane (CNVM)Irregular, abnormal blood vessels beneath the retina, often seen in the macula with red / green / brown hue, which may leak fluid or blood, causing retinal distortion

Fundus photography pearls for AMD:

  • Use the green-free filter to enhance the visibility of drusen. This filter increases contrast between the yellowish drusen deposits and the surrounding retina, making them stand out, especially in the early stages of dry AMD.10
  • Fundus photography is essential for detecting early signs of AMD, such as drusen and pigment epithelial detachments. Early identification allows for monitoring progression, especially in dry AMD, before it progresses to the wet form.
  • Regular fundus photography is key for monitoring geographic atrophy, a late-stage manifestation of dry AMD. It helps clinicians observe the extent of retinal tissue loss and plan for intervention if needed.
    • The leading edge of progressing geographic atrophy often shows hyperfluorescence on FAF. This hyperfluorescence indicates metabolic activity at the outer retina, and its appearance is useful for assessing disease progression.2
    • This can help identify areas of active degeneration and predict the potential expansion of atrophic regions.
  • Widefield imaging provides a broader view of the retina, which is useful for detecting AMD-related changes, particularly in areas that might not be visible with a standard fundus exam. This is especially helpful for detecting peripheral lesions or early-stage changes.
  • Fundus photography can help identify CNVMs, abnormal blood vessels that form under the retina in wet AMD. Detecting CNVM early is crucial for preventing further vision loss and guiding treatment options.
  • Fundus photography is an effective tool for educating patients about the progression of AMD. Visualizing changes such as drusen, geographic atrophy, or hemorrhages can help patients understand the severity of the condition and the importance of adhering to treatment and follow-up visits.
Figures 3 and 4: Fundus images of intermediate AMD with large drusen and advanced dry AMD (i.e., geographic atrophy), respectively.
Intermediate AMD with large drusen
Figure 3: Courtesy of Julie Rodman, OD, MSc, FAAO.
Geographic atrophy
Figure 4: Courtesy of Julie Rodman, OD, MSc, FAAO.

Retinitis pigmentosa

Retinitis pigmentosa (RP) is a hereditary condition that leads to progressive retinal degeneration, initially affecting night vision and peripheral vision, followed by central vision loss.8,9 Patients often present with night blindness and reduced peripheral vision.
Table 4: List of clinical characteristics of retinitis pigmentosa that can be identified on fundus imaging.8,9
Clinical FindingsDescription
Bone spicule-like pigmentScattered pigment deposits in the peripheral retina
Attenuated retinal vesselsNarrowing of the retinal vessels
Optic nerve pallor Seen in advanced stages of retinitis pigmentosa

Fundus photography pearls for RP:

  • FAF can assist with early diagnosis, which is key for genetic counseling. Active areas of progression will demonstrate hyperfluorescence due to lipofuscin deposits, while atrophy will be hypofluorescent
Figure 5: Fundus images of bone spicules in the periphery, attenuated blood vessels, and waxy pallor of the optic disc due to retinitis pigmentosa.
Retinitis pigmentosa
Figure 5: Courtesy of Inrava Khasnabish, OD, FAAO.

Retinopathy of prematurity (ROP)

Advancements in retinal imaging for pediatric and premature populations have led to the development of specialized tools such as handheld fundus imaging systems.12 These technologies enable clinicians to perform effective retinal screenings in infants and young children who may be unable to cooperate with traditional imaging methods.
In particular, early detection of retinopathy of prematurity (ROP), a leading cause of childhood blindness, has been greatly improved with these innovations, allowing for more timely interventions. ROP affects premature infants, characterized by abnormal retinal blood vessel growth. If untreated, it can lead to retinal detachment and blindness.8,9
Table 5: Breakdown of ROP stages with corresponding descriptions of clinical characteristics on fundus imaging.8,9
ROP StageFundus AppearanceDescription
Stage 1Line of demarcationA white line that separates the vascularized retina from the avascular retina, indicating the boundary of retinal development
Stage 2Ridge formationA raised, white ridge at the junction of vascular and avascular retina, signifying more advanced retinal neovascular activity
Extraretinal neovascularizationFine, frond-like vessels growing outward from the retina, marking the onset of neovascular changes
Stage 3Exuberant neovascularizationProminent, fragile blood vessels extend into the vitreous, leading to increased risk of hemorrhage and traction
Plus diseaseDilated and tortuous blood vessels, typically seen in the posterior retina, indicating worsening vascular pathology
Retinal edemaSwelling of the retina, often causing blurred margins of the optic disc, indicative of worsening retinal pathology
Stage 4Retinal foldsWrinkling of the retina caused by fibrous tissue traction, leading to deformation of the retinal structure
Vitreous hemorrhagePresence of blood in the vitreous cavity, often resulting from ruptured neovascular vessels
Stage 5Complete retinal detachmentPresence of blood in the vitreous cavity, often resulting from ruptured neovascular vessels
Severe vitreous hemorrhageComplete obscuration of the retina due to massive blood accumulation in the vitreous, hindering vision

Fundus photography pearls for ROP:

  • Retinopathy of prematurity is a leading cause of blindness in premature infants.
  • Regular screening in preterm infants is essential for early intervention.
  • Capturing fundus photography on the pediatric population can be challenging, external fixation (sometimes with toys) assist tremendously with capturing fundus photos
Figures 6 and 7: Fundus images of stage 1 and stage 3 ROP, respectively.
stage 1 rop
Figure 6: ROP fundus images© Xinyu Zhao, et al. Image cropped and used under CC BY 4.0.
stage 3 rop
Figure 3: ROP fundus images© Xinyu Zhao, et al. Image cropped and used under CC BY 4.0.

Other technologies and developments enhancing fundus examination

Advancements in fundus imaging techniques have substantially improved the ability to diagnose, monitor, and manage retinal diseases.
These innovations offer optometrists and ophthalmologists enhanced diagnostic tools to detect early signs of retinal conditions, track disease progression, and guide treatment decisions.

OCT angiography (OCTA)

OCTA is a groundbreaking, non-invasive imaging technique that visualizes retinal and choroidal blood flow without the need for dye injection.
By detecting variations in the light reflection from blood vessels, OCTA produces high-resolution images of retinal vasculature. This makes it particularly valuable for identifying early microvascular changes in conditions such as diabetic retinopathy, AMD, and retinal vein occlusions.13
OCTA allows for the visualization of both superficial and deep capillary networks, helping to detect early pathologic change such as capillary drop-out or neovascularization, prior to structural manifestations becoming apparent.14
This technology can be meaningful for the optometrist in order to make proper referrals for proliferative retinopathy, and is likewise useful for a retinal specialist in monitoring responses to anti-VEGF therapy.

Artificial intelligence (AI)

AI has made significant strides in retinal imaging, enhancing the diagnostic process with machine learning algorithms capable of analyzing retinal images with remarkable accuracy.
AI systems can automatically detect and classify retinal diseases, including diabetic retinopathy, AMD, and glaucoma, by identifying key features such as microaneurysms, hemorrhages, and drusen.
These AI tools can also quantify biomarkers—such as the size of drusen or the extent of hemorrhages—which is crucial for tracking disease progression and determining treatment effectiveness.14
With the ability to predict disease progression based on historical data, AI is enhancing early detection, streamlining screening processes, and enabling more personalized treatment plans.

Fusion of OCT and OCTA

This emerging technique combines structural imaging with functional vascular information.2,14 This integrated approach provides a more comprehensive view of retinal diseases, particularly those with both structural and vascular components, such as DME and wet AMD.
The combination of OCT’s detailed imaging of retinal thickness and OCTA’s visualization of blood flow enhances the ability to track disease progression and evaluate responses to therapy, making it an essential tool for managing complex retinal conditions.2

Billing considerations for fundus photography

As of 2025, there are significant updates in the billing and reimbursement landscape for fundus photography and related imaging technologies, particularly with the Centers for Medicaid and Medicare Services' new fee schedule.15
One of the most notable changes is the introduction of a new CPT code for OCTA. This advanced imaging technique, which allows for noninvasive visualization of retinal blood vessels without dye injection, has been increasingly adopted in ophthalmic practices.
The new CPT code 92137 for OCTA, effective January 1, 2025, combines traditional OCT of the retina with OCTA in a single procedure, offering a more accurate representation of the service. However, practitioners should note that OCTA cannot be billed in the same visit as other OCT codes (92133 or 92134), so careful attention to coding is necessary.
Approximate national average reimbursement for 92137 per the Medicare Physician Fee Schedule is $56.93, compared to its counterparts 92134 (OCT retina) $31.38 and 92235 (fluorescein angiography) $152.68.15

Using modifier 52 for coding fundus photography

In addition to the new OCTA code, another important consideration for fundus photography is the proper use of modifier 52. This modifier is used when a reduced service is performed, such as testing only one eye rather than both in a bilateral procedure like fundus photography (CPT code 92250).
Fundus photography is generally a bilateral service, meaning that it is expected to be performed on both eyes. If only one eye is imaged, the service is considered reduced, and modifier 52 should be applied to indicate that a partial service was provided.
This helps ensure that the practice is paid appropriately for the reduced service while avoiding claim denials. It's also important to remember that OCTA and fundus photography are mutually exclusive for billing, so when both are performed on the same day, they must be billed separately, with proper justification.
Managing the workflow for fundus photography, along with staying on top of coding changes, is key to maximizing efficiency and revenue. For example, some payors may reimburse for screening fundus photos in diabetic patients (92250 CPT code + E11.9 ICD-10 code), providing a valuable opportunity for practices that manage a large diabetic population.
Keeping up with these billing nuances and educating both staff and patients about the importance of retinal imaging, especially for those at risk of retinal diseases, will help ensure practices not only remain compliant but also improve patient outcomes and financial health.15

Tip: Always verify insurance coverage for diabetic screenings before performing the service to ensure proper reimbursement.

Conclusion

Fundus photography is a critical tool for optometrists in the diagnosis and monitoring of various retinal diseases. Understanding the biomarkers associated with these conditions, such as hemorrhages, exudates, and neovascularization, is essential for early detection and timely intervention.
With ongoing advancements in imaging technology, optometrists are equipped with the ability to identify subtle retinal changes that may have significant clinical implications. Keep honing your skills in fundus imaging interpretation, as it is one of the most powerful ways to safeguard and preserve your patients' vision.
  1. Panwar N, Huang P, Lee J, et al. Fundus Photography in the 21st Century--A Review of Recent Technological Advances and Their Implications for Worldwide Healthcare. Telemed J E Health. 2016;22(3):198-208. doi:10.1089/tmj.2015.0068.
  2. O'Keefe GD, Breda J, Tripathy K, et al. Optical Coherence Tomography Angiography. EyeWiki. https://eyewiki.org/Optical_Coherence_Tomography_Angiography.
  3. Nagiel A, Lalane RA, Sadda SR, Schwartz SD. Ultra-Widefield Fundus Imaging: A Review of Clinical Applications and Future Trends. Retina. 2016;36(4):660-678. doi:10.1097/IAE.0000000000000937.
  4. Bhagat N, Pole C. Fundus Autofluorescence. EyeWiki. April 13, 2025. https://eyewiki.org/Fundus_Autofluorescence.
  5. Eisma JH, Dulle JE, Fort PE. Current knowledge on diabetic retinopathy from human donor tissues. World J Diabetes. 2015 Mar 15;6(2):312-20.
  6. Khasnabish I. A Guideline for Managing Patients with Diabetic Retinopathy. Modern Optometry. November/December 2021. https://modernod.com/articles/2021-nov-dec/a-guideline-for-managing-patients-with-dr?c4src=article:infinite-scroll.
  7. Ferrucci S. Standard Tools and Tests for Diagnosing Diabetic Retinopathy. Modern Optometry. June 2019. https://modernod.com/articles/2019-june/standard-tools-and-tests-fordiagnosing-diabetic-retinopathy?c4src=article:infinite-scroll.
  8. Yanoff M, Duker JS, Augsburguer JJ, Al E. Ophthalmology. Elsevier Saunders; 2014.
  9. Bagheri N. The Wills Eye Manual: Office and Emergency Room Diagnosis and Treatment of Eye Disease. Wolters Kluwer; 2017.
  10. Venkatesh P, Sharma R, Vashist N, et al. Detection of retinal lesions in diabetic retinopathy: comparative evaluation of 7-field digital color photography versus red-free photography. Int Ophthalmol. 2015;35(5), 635–640. doi:10.1007/s10792-012-9620-7
  11. Salm A, Panozzo G, Lanza M, Lim L. Comparison of widefield swept-source optical coherence tomography angiography with ultra-widefield colour fundus photography and fluorescein angiography for detection of lesions in diabetic retinopathy. Br J Ophthalmol. 2021;105(4):577-584. doi:10.1136/bjophthalmol-2020-316497
  12. Lu L, Ausayakhun S, Ausayakuhn S, et al. Diagnostic Accuracy of Handheld Fundus Photography: A Comparative Study of Three Commercially Available Cameras. PLOS Digit Health. 2022;1(11): e0000131. doi:10.1371/journal.pdig.0000131.
  13. Waheed NK, Rosen RB, Jia Y, et al. Optical Coherence Tomography Angiography in Diabetic Retinopathy. Prog Retin Eye Res. 2023:97:101206. doi:10.1016/j.preteyeres.2023.101206.
  14. Gulshan V, Peng L, Coram M, et al. Development and Validation of a Deep Learning Algorithm for Detection of Diabetic Retinopathy in Retinal Fundus Photographs. JAMA. 2016;316(22):2402–2410. doi:10.1001/jama.2016.17216
  15. Calendar year (CY) 2025 Medicare Physician Fee Schedule Final Rule. Centers for Medicare & Medicaid Services. Published November 1, 2024. https://www.cms.gov/newsroom/fact-sheets/calendar-year-cy-2025-medicare-physician-fee-schedule-final-rule.
Inrava Khasnabish, OD, FAAO
About Inrava Khasnabish, OD, FAAO

Inrava Khasnabish, OD, FAAO, is currently the Director of Optometry at Pearle Vision in New York City, New York. She received her Bachelor's degree in pre-medical studies and Doctor of Optometry at Massachusetts College of Pharmacy and Health Sciences (MCPHS) as an inaugural student in the 3+4 program.

Dr. Khasnabish completed optometry externships in Massachusetts and Rhode Island and then pursued a residency in ocular disease/family practice with an emphasis on rural area medicine in Virginia.

Inrava Khasnabish, OD, FAAO
How would you rate the quality of this content?
Eyes On Eyecare Site Sponsors
Astellas Logo